Reducing Site Burden for Oncology Trials

Merck’s Global Trial Optimization (GTO) team supports feasibility and recruitment and retention strategies on behalf of Global Clinical Trial Operations. Merck recognizes that successful clinical trial recruitment is, in part, attributable to ensuring the burden of execution on research sites with which they partner is eased. Sites across the industry have historically been tasked with tracking and reporting on the status of clinical trial candidates over long and complicated trials with suboptimal, manual, and often duplicative tools. It’s a dynamic that can lead to lengthy trial delays, especially in oncology where protocols are complex and the demands on sites is heavy.

In this webinar, you’ll learn how the GTO team at Merck is using data and technology to reduce site burden related to oncology trial enrollment and visit management so that research staff can focus on their work with patients.